Filter
818
Text search:
drug
prices
Featured
Recommendations
74
New Publications
247
Language
Document type
No document type
486
Studies & Reports
171
Guidelines
77
Strategic & Response Plan
36
Manuals
21
Situation Updates
8
Fact sheets
8
Training Material
4
Resource Platforms
3
Infographics
3
Brochures
1
Countries / Regions
Global
36
India
30
Kenya
28
Uganda
21
Myanmar / Burma
20
Western and Central Europe
17
Liberia
15
Nepal
15
Malawi
15
Zambia
14
South Africa
14
Ukraine
12
Sierra Leone
11
Nigeria
11
Ghana
11
Tanzania
11
Bangladesh
11
Latin America and the Carribbean
11
Zimbabwe
9
Africa
9
Ethiopia
8
Philippines
8
Syria
8
Indonesia
8
Namibia
8
Congo, Democratic Republic of
7
Botswana
7
South–East Asia Region
7
Cameroon
6
Mozambique
6
Asia
6
Eastern Europe
6
Rwanda
5
Senegal
4
Haiti
4
Cambodia
4
Burkina Faso
3
Eswatini/ Swaziland
3
Lesotho
3
Venezuela
3
Tajikistan
3
Guinea
2
Pakistan
2
Jordan
2
North Macedonia
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Russia
2
Moldova
2
Kyrgyzstan
2
Georgia
2
USA
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
Thailand
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Switzerland
1
Serbia
1
Colombia
1
Bolivia
1
Libya
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Bhutan
1
North Korea
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
316
Clinical Guidelines
80
Public Health
44
Pharmacy & Technologies
20
Key Resources
19
Women & Child Health
18
Capacity Building
4
Toolboxes
HIV
108
Mental Health
79
Pharmacy
56
TB
47
AMR
47
COVID-19
31
NCDs
19
Global Health Education
17
Health Financing Toolbox
17
Conflict
12
NTDs
11
Planetary Health
9
Malaria
9
Ebola & Marburg
8
Refugee
8
Disability
7
Caregiver
6
Polio
4
Natural Hazards
3
Rapid Response
3
Cholera
2
2.0 Rapid Response
1
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
People living with HIV who have a low CD4 count are at a much higher risk of falling ill from TB infection than HIV negative people.
It is important to offer both HIV testing to TB patients and TB diagnosis in HIV patients. Early detection and effective treatment are essential to preventing TB
...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a
...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet
...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi
...
Towards the Peoples Health Assembly Book - 4
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Epidemiology, Control, and Financing
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta
...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there
...
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson
...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach
...
Alcohol misuses
Substance use disorders
Chapter G.1
This report challenges policy-makers and political leaders to tackle fossil fuel production and consumption as a health control issue, in the same way that smoking has been reduced and regulated. Fossil fuel combustion is a major source of toxic air pollution that kills 7 million people every year,
...